These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28322323)

  • 1. Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy.
    Liao PL; Lin CH; Li CH; Tsai CH; Ho JD; Chiou GC; Kang JJ; Cheng YW
    Sci Rep; 2017 Mar; 7():44985. PubMed ID: 28322323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR7 deficiency contributes to attenuated diabetic retinopathy via inhibition of inflammatory response.
    Liao YR; Li ZJ; Zeng P; Lan YQ
    Biochem Biophys Res Commun; 2017 Nov; 493(2):1136-1142. PubMed ID: 28843858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
    Xu C; Liu G; Liu X; Wang F
    Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chrysin Ameliorates Malfunction of Retinoid Visual Cycle through Blocking Activation of AGE-RAGE-ER Stress in Glucose-Stimulated Retinal Pigment Epithelial Cells and Diabetic Eyes.
    Kang MK; Lee EJ; Kim YH; Kim DY; Oh H; Kim SI; Kang YH
    Nutrients; 2018 Aug; 10(8):. PubMed ID: 30096827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.
    Holoman NC; Aiello JJ; Trobenter TD; Tarchick MJ; Kozlowski MR; Makowski ER; De Vivo DC; Singh C; Sears JE; Samuels IS
    J Neurosci; 2021 Apr; 41(14):3275-3299. PubMed ID: 33622781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging roles of clusterin on reduction of both blood retina barrier breakdown and neural retina damage in diabetic retinopathy.
    Zhang C; Nie J; Feng L; Luo W; Yao J; Wang F; Wang H
    Discov Med; 2016 Apr; 21(116):227-37. PubMed ID: 27232509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats.
    Desjardins DM; Yates PW; Dahrouj M; Liu Y; Crosson CE; Ablonczy Z
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2706-13. PubMed ID: 27191823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous insulin signaling in the RPE contributes to the maintenance of rod photoreceptor function in diabetes.
    Tarchick MJ; Cutler AH; Trobenter TD; Kozlowski MR; Makowski ER; Holoman N; Shao J; Shen B; Anand-Apte B; Samuels IS
    Exp Eye Res; 2019 Mar; 180():63-74. PubMed ID: 30543793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy.
    Rosales MA; Silva KC; Duarte DA; de Oliveira MG; de Souza GF; Catharino RR; Ferreira MS; Lopes de Faria JB; Lopes de Faria JM
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2921-32. PubMed ID: 24699383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10-induced modulation of macrophage polarization suppresses outer-blood-retinal barrier disruption in the streptozotocin-induced early diabetic retinopathy mouse model.
    Lee SJ; Noh SE; Jo DH; Cho CS; Park KS; Kim JH
    FASEB J; 2024 May; 38(9):e23638. PubMed ID: 38713098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET Imaging of Vesicular Monoamine Transporter 2 in Early Diabetic Retinopathy Using [
    Li J; Chen P; Bao Y; Sun Y; He J; Liu X
    Mol Imaging Biol; 2020 Oct; 22(5):1161-1169. PubMed ID: 31650482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonising Wnt/β-catenin signalling ameliorates lens-capsulotomy-induced retinal degeneration in a mouse model of diabetes.
    Hombrebueno JR; Ali IHA; Ma JX; Chen M; Xu H
    Diabetologia; 2018 Nov; 61(11):2433-2446. PubMed ID: 30019207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal dysfunction parallels morphologic alterations and precede clinically detectable vascular alterations in Meriones shawi, a model of type 2 diabetes.
    Hammoum I; Benlarbi M; Dellaa A; Kahloun R; Messaoud R; Amara S; Azaiz R; Charfeddine R; Dogui M; Khairallah M; Lukáts Á; Ben Chaouacha-Chekir R
    Exp Eye Res; 2018 Nov; 176():174-187. PubMed ID: 30009825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.
    Ibrahim AS; Tawfik AM; Hussein KA; Elshafey S; Markand S; Rizk N; Duh EJ; Smith SB; Al-Shabrawey M
    Biochim Biophys Acta; 2015 Mar; 1851(3):290-8. PubMed ID: 25562624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of aryl hydrocarbon receptor by azatyrosine-phenylbutyric hydroxamide inhibits progression of diabetic retinopathy mice.
    Fitriana I; Wu CH; Hsu TJ; Chan YJ; Li CH; Lee CC; Hsiao G; Cheng YW
    Biochem Pharmacol; 2023 Sep; 215():115700. PubMed ID: 37482199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
    Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
    Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
    Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
    Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of levetiracetam in mouse diabetic retinopathy: Effect on glucose transporter-1 and GAP43 expression.
    Mohammad HMF; Sami MM; Makary S; Toraih EA; Mohamed AO; El-Ghaiesh SH
    Life Sci; 2019 Sep; 232():116588. PubMed ID: 31226418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.
    Jiang S; Chen X
    Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.